Novel Sulfur Metabolites of Garlic Attenuate Cardiac Hypertrophy and Remodeling Through Induction of Na/K-ATPase Expression

Overview

Journal Front Pharmacol

Date 2017 Feb 15

PMID 28194108

Citations 19

Authors

Tarak N Khatua

Roshan M Borkar

Soheb A Mohammed

Amit K Dinda

R Srinivas

Sanjay K Banerjee

Affiliations

Soon will be listed here.

Abstract

Epidemiologic studies show an inverse correlation between garlic consumption and progression of cardiovascular disease. However, the molecular basis for the beneficial effect of garlic on the heart is not known. Therefore, the objective of the present study was to (1) investigate the effect of raw garlic on isoproterenol (Iso) induced cardiac hypertrophy (2) find the active metabolites of garlic responsible for the beneficial effect. Cardiac hypertrophy was induced in rats by subcutaneous single injection of Iso 5 mg kg day for 15 days and the effect of garlic (250 mg/kg/day orally) was evaluated. Garlic metabolites in were identified by LC/MS study. The effect of garlic and its metabolites were evaluated against hypertrophy in H9C2 cells. Garlic normalized cardiac oxidative stress after Iso administration. Cardiac pathology and mitochondrial enzyme activities were improved in hypertrophy heart after garlic administration. Decreased Na/K-ATPase protein level that observed in hypertrophy heart was increased after garlic administration. We identified three garlic metabolites in rat serum. To confirm the role of garlic metabolites on cardiac hypertrophy, Na/K-ATPase expression and intracellular calcium levels were measured after treating H9C2 cells with raw garlic and two of its active metabolites, allyl methyl sulfide and allyl methyl sulfoxide. Raw garlic and both metabolites increased Na/K-ATPase protein level and decreased intracellular calcium levels and cell size in Iso treated H9C2 cells. This antihypertrophic effect of garlic and its sulfur metabolites were lost in H9C2 cells in presence of Na/K-ATPase inhibitor. In conclusion, garlic and its active metabolites increased Na/K-ATPase in rat heart, and attenuated cardiac hypertrophy and associated remodeling. Our data suggest that identified new garlic metabolites may be useful for therapeutic intervention against cardiac hypertrophy.

Citing Articles

Garlic bioactive substances and their therapeutic applications for improving human health: a comprehensive review.

El-Saadony M, Saad A, Korma S, Salem H, Abd El-Mageed T, Sami Alkafaas S Front Immunol. 2024; 15:1277074.

PMID: 38915405 PMC: 11194342. DOI: 10.3389/fimmu.2024.1277074.

Garlic against Heart-related Ailments: Chemistry, Pharmacology, and Future Perspective.

Chaurasia P, Bharati S, Singh S Mini Rev Med Chem. 2023; 24(5):521-530.

PMID: 37605421 DOI: 10.2174/1389557523666230821102512.

Medicinal and therapeutic properties of garlic, garlic essential oil, and garlic-based snack food: An updated review.

Verma T, Aggarwal A, Dey P, Chauhan A, Rashid S, Chen K Front Nutr. 2023; 10:1120377.

PMID: 36875845 PMC: 9978857. DOI: 10.3389/fnut.2023.1120377.

Characterization of volatile organic compounds with anti-atherosclerosis effects in Bge. and G. Don by head space solid phase microextraction coupled with gas chromatography tandem mass spectrometry.

Qin Z, Duan S, Li Y, Li X, Xing H, Yao Z Front Nutr. 2023; 10:996675.

PMID: 36819690 PMC: 9929146. DOI: 10.3389/fnut.2023.996675.

Traditional uses, phytochemistry, pharmacology and toxicology of garlic (), a storehouse of diverse phytochemicals: A review of research from the last decade focusing on health and nutritional implications.

Tudu C, Dutta T, Ghorai M, Biswas P, Samanta D, Oleksak P Front Nutr. 2022; 9:949554.

PMID: 36386956 PMC: 9650110. DOI: 10.3389/fnut.2022.929554.

References

Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N . Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999; 85(4):357-63. DOI: 10.1161/01.res.85.4.357. View

Frey N, Olson E . Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003; 65:45-79. DOI: 10.1146/annurev.physiol.65.092101.142243. View

Banerjee S, Maulik S . Effect of garlic on cardiovascular disorders: a review. Nutr J. 2003; 1:4. PMC: 139960. DOI: 10.1186/1475-2891-1-4. View

Schwinger R, Bundgaard H, Muller-Ehmsen J, Kjeldsen K . The Na, K-ATPase in the failing human heart. Cardiovasc Res. 2003; 57(4):913-20. DOI: 10.1016/s0008-6363(02)00767-8. View

F Turrens J . Mitochondrial formation of reactive oxygen species. J Physiol. 2003; 552(Pt 2):335-44. PMC: 2343396. DOI: 10.1113/jphysiol.2003.049478. View

Rahman K, Lowe G . Garlic and cardiovascular disease: a critical review. J Nutr. 2006; 136(3 Suppl):736S-740S. DOI: 10.1093/jn/136.3.736S. View

Kang Y . Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death. Toxicol Pathol. 2006; 34(1):58-66. DOI: 10.1080/01926230500419421. View

Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G . Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res. 1991; 69(6):1476-86. DOI: 10.1161/01.res.69.6.1476. View

Takimoto E, Kass D . Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2006; 49(2):241-8. DOI: 10.1161/01.HYP.0000254415.31362.a7. View

10.

Civitarese A, Carling S, Heilbronn L, Hulver M, Ukropcova B, Deutsch W . Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007; 4(3):e76. PMC: 1808482. DOI: 10.1371/journal.pmed.0040076. View

11.

Osadchii O . Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev. 2007; 12(1):66-86. DOI: 10.1007/s10741-007-9007-4. View

12.

de Souza H, Penteado D, Martin-Pinge M, Barbosa Neto O, Teixeira V, Blanco J . Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training. Arq Bras Cardiol. 2007; 89(2):88-93, 99-104. DOI: 10.1590/s0066-782x2007001400005. View

13.

Jeong K, Kwon H, Min C, Pak Y . Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts. Exp Mol Med. 2009; 41(4):226-35. PMC: 2679235. DOI: 10.3858/emm.2009.41.4.025. View

14.

Banerjee S, McGaffin K, Pastor-Soler N, Ahmad F . SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res. 2009; 84(1):111-8. PMC: 2741348. DOI: 10.1093/cvr/cvp190. View

15.

Galindo C, Skinner M, Errami M, Olson L, Watson D, Li J . Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol. 2009; 9:23. PMC: 2799380. DOI: 10.1186/1472-6793-9-23. View

16.

Liu C, Cao F, Tang Q, Yan L, Dong Y, Zhu L . Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. J Nutr Biochem. 2010; 21(12):1238-50. DOI: 10.1016/j.jnutbio.2009.11.001. View

17.

Wang X, Wang Q, Guo W, Zhu Y . Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep. 2010; 31(2):87-98. PMC: 2973233. DOI: 10.1042/BSR20100003. View

18.

Ho C, Lopez B, Coelho-Filho O, Lakdawala N, Cirino A, Jarolim P . Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010; 363(6):552-63. PMC: 3049917. DOI: 10.1056/NEJMoa1002659. View

19.

Sharma A, Mediratta P, Sharma K, Fahim M . Lipotab, a polyherbal formulation, attenuates isoprenaline-induced left ventricular remodeling and heart failure in rats. Hum Exp Toxicol. 2010; 30(8):1000-8. DOI: 10.1177/0960327110384529. View

20.

Rehsia N, Dhalla N . Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol. 2011; 15(4):e86-95. PMC: 3016066. View